Evidence map›Paper›PMID 30961603›Full record

ArticleMalaria journal2019

Prioritizing the scale-up of interventions for malaria control and elimination.

Peter Winskill, Patrick G Walker, Richard E Cibulskis, Azra C Ghani

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 4 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 4 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Peter WinskillMRC Centre of Global Infectious Disease Analysis, School of Public Health, Faculty of Medicine, Imperial College London, St Mary's Campus, London, W2 1PG, UK. p.winskill@imperial.ac.uk.ORCID http://orcid.org/0000-0003-3001-4959
Patrick G WalkerMRC Centre of Global Infectious Disease Analysis, School of Public Health, Faculty of Medicine, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
Richard E CibulskisGlobal Malaria Programme, World Health Organization, Geneva, Switzerland.
Azra C GhaniMRC Centre of Global Infectious Disease Analysis, School of Public Health, Faculty of Medicine, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
Imperial College London · GBWorld Health Organization · CH

Funding

Medical Research Council MR/R015600/1MRF MR/LO12189/1Wellcome TrustWorld Health Organization 001
6 · The paper itself

Abstract

backgroundA core set of intervention and treatment options are recommended by the World Health Organization for use against falciparum malaria. These are treatment, long-lasting insecticide-treated bed nets, indoor residual spraying, and chemoprevention options. Both domestic and foreign aid funding for these tools is limited. When faced with budget restrictions, the introduction and scale-up of intervention and treatment options must be prioritized.

methodsEstimates of the cost and impact of different interventions were combined with a mathematical model of malaria transmission to estimate the most cost-effective prioritization of interventions. The incremental cost effectiveness ratio was used to select between scaling coverage of current interventions or the introduction of an additional intervention tool.

resultsPrevention, in the form of vector control, is highly cost effective and scale-up is prioritized in all scenarios. Prevention reduces malaria burden and therefore allows treatment to be implemented in a more cost-effective manner by reducing the strain on the health system. The chemoprevention measures (seasonal malaria chemoprevention and intermittent preventive treatment in infants) are additional tools that, provided sufficient funding, are implemented alongside treatment scale-up. Future tools, such as RTS,S vaccine, have impact in areas of higher transmission but were introduced later than core interventions.

conclusionsIn a programme that is budget restricted, it is essential that investment in available tools be effectively prioritized to maximize impact for a given investment. The cornerstones of malaria control: vector control and treatment, remain vital, but questions of when to scale and when to introduce other interventions must be rigorously assessed. This quantitative analysis considers the scale-up or core interventions to inform decision making in this area.

Indexed as

Cost-Benefit AnalysisCommunicable Disease ControlDisease EradicationHumansMalaria, FalciparumModels, TheoreticalCost-effectiveInterventionsMalariaPlasmodium falciparumPrioritizationScale-up

Identifiers

PMID30961603
PMCPMC6454681
OpenAlexW2943952460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.